U.S. Bioanalytical Methods Guidance Defines Three Levels of Validation

A U.S. Food and Drug Administration draft guidance on validating bioanalytical methods for evaluating drugs, their metabolites and biomarkers — techniques the agency calls “critical” for conducting successful clinical and nonclinical pharmacology studies — has been revised 12 years after it was first issued.
International Pharmaceutical Regulatory Monitor